Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

423 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial.
Becker JC, Ugurel S, Leiter U, Meier F, Gutzmer R, Haferkamp S, Zimmer L, Livingstone E, Eigentler TK, Hauschild A, Kiecker F, Hassel JC, Mohr P, Fluck M, Thomas I, Garzarolli M, Grimmelmann I, Drexler K, Spillner AN, Eckhardt S, Schadendorf D; DeCOG. Becker JC, et al. Lancet. 2023 Sep 2;402(10404):798-808. doi: 10.1016/S0140-6736(23)00769-9. Epub 2023 Jul 11. Lancet. 2023. PMID: 37451295 Clinical Trial.
Adjuvant treatment and outcome of stage III melanoma patients: Results of a multicenter real-world German Dermatologic Cooperative Oncology Group (DeCOG) study.
Lodde GC, Hassel J, Wulfken LM, Meier F, Mohr P, Kähler K, Hauschild A, Schilling B, Loquai C, Berking C, Hüning S, Eckardt J, Gutzmer R, Reinhardt L, Glutsch V, Nikfarjam U, Erdmann M, Beckmann CL, Stang A, Kowall B, Galetzka W, Roesch A, Ugurel S, Zimmer L, Schadendorf D, Forschner A, Livingstone E. Lodde GC, et al. Among authors: berking c. Eur J Cancer. 2023 Sep;191:112957. doi: 10.1016/j.ejca.2023.112957. Epub 2023 Jun 22. Eur J Cancer. 2023. PMID: 37487400
[Simultaneous presentation of two skin lesions suspected of being malignant].
Kaufmann MD, Erdmann M, Schliep S, Voskens C, Berking C, Bauerschmitz JP. Kaufmann MD, et al. Among authors: berking c. Dermatologie (Heidelb). 2024 Sep;75(9):747-750. doi: 10.1007/s00105-024-05365-0. Epub 2024 Jun 3. Dermatologie (Heidelb). 2024. PMID: 38831014 German. No abstract available.
Poor Adherence to Self-Applied Topical Drug Treatment Is a Common Source of Low Lesion Clearance in Patients with Actinic Keratosis-A Cross-Sectional Study.
Koch EAT, Steeb T, Bender-Säbelkampf S, Busch D, Feustel J, Kaufmann MD, Maronna A, Meder C, Ronicke M, Toussaint F, Wellein H, Berking C, Heppt MV. Koch EAT, et al. Among authors: berking c. J Clin Med. 2023 Jun 1;12(11):3813. doi: 10.3390/jcm12113813. J Clin Med. 2023. PMID: 37298008 Free PMC article.
Case Report: The many faces of bullous pemphigoid.
Rechtien L, Sollfrank L, Foerster Y, Berking C, Sticherling M. Rechtien L, et al. Among authors: berking c. Front Immunol. 2023 Oct 12;14:1272742. doi: 10.3389/fimmu.2023.1272742. eCollection 2023. Front Immunol. 2023. PMID: 37901243 Free PMC article.
423 results